Document is current
Any future updates will be listed below
-
Authors
Nakamura, Akihiro
Jo, Sungsin https://orcid.org/0000-0003-3034-5029
Nakamura, Sayaka
Aparnathi, Mansi K.
Boroojeni, Shaghayegh Foroozan
Korshko, Mariia
Park, Ye-Soo
Gupta, Himanshi
Vijayan, Sandra
Rockel, Jason S.
Kapoor, Mohit
Jurisica, Igor
Kim, Tae-Hwan
Haroon, Nigil
-
Funding
Funding for this research was provided by:
Canada Foundation for Innovation (225404, 30865)
Ontario Research Foundation (RDI34876, E10-020)
National Research Foundation of Korea (KRF-2021R1A6A1A03038899)
Arthritis Society
- License Information
-
More Information
Article History
Received: 29 October 2023
Accepted: 8 May 2024
First Online: 5 June 2024
Competing interests
: AN and NH have filed a US provisional patent (METHODS OF TREATING SPONDYLOARTHRITIS AND SYMPTOMS THEREOF; No. 63/106,859). AN has received speaker honorarium and/or consultant fees from AbbVie, JAMP, and Novartis. NH has received consulting fees from AbbVie, Amgen, Eli Lilly, Janssen, Merck, Novartis and UCB.
